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Abstract
After ovulation, somatic cells of the ovarian follicle (theca and granulosa cells) become the small 
and large luteal cells of the corpus luteum. Aside from known cell type-specific receptors and 
steroidogenic enzymes, little is known about the differences in the gene expression profiles of 
these four cell types. Analysis of the RNA present in each bovine cell type using Affymetrix 
microarrays yielded new cell-specific genetic markers, functional insight into the behavior of each 
cell type via Gene Ontology Annotations and Ingenuity Pathway Analysis, and evidence of small 
and large luteal cell lineages using Principle Component Analysis. Enriched expression of select 
genes for each cell type was validated by qPCR. This expression analysis offers insight into cell-
specific behaviors and the differentiation process that transforms somatic follicular cells into luteal 
cells.
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1. Introduction
1.1. Mammalian ovarian follicle and corpus luteum structure and function
A key feature of the mammalian female reproductive cycle is the ovarian follicle, which 
contains an oocyte, granulosa cells (GCs), and theca cells (TCs). The somatic GCs and TCs 
create a microenvironment that determines oocyte quality and maturation by synthesizing 
steroid and peptide hormones, secreting extracellular matrix, and signaling to control the 
development and health of the follicle/oocyte (Albertini et al., 2001; Hennet and Combelles, 
2012). The TCs are primarily responsible for the synthesis of androgens within the ovary via 
the enzyme cytochrome P450 17A1 (CYP17A1) (Young and McNeilly, 2010). The mural 
GCs are positioned against the basement membrane on the periphery of the antrum while the 
cumulus GCs surround and can physically interact with the oocyte. Both of these GCs 
convert androgens to estrogens with the cytochrome P450 enzyme aromatase (CYP19A1) 
(Erickson and Hsueh, 1978). When ovulation occurs in response to a surge of luteinizing 
hormone (LH), the following series of events occurs: the follicle ruptures, the cumulus-
oocyte-complex is released, and the remaining GCs and TCs differentiate into luteal cells as 
the ovulated follicle transforms into the corpus luteum (Stouffer and Hennebold, 2015). The 
morphology of the corpus luteum consists of large luteal cells (LLCs, ≥25 μm) and small 
luteal cells (SLCs, 12–25 μm) intermixed and accompanied by other cells that migrate into 
the tissue (Donaldson and Hansel, 1965; Fitz et al., 1982; Heath et al., 1983). Both LLCs 
and SLCs secrete progesterone, a steroid hormone that is required for the maintenance of 
pregnancy in most species including humans and cattle. However, in cows and sheep the 
SLCs contain the majority of the luteinizing hormone receptors (LHCGR) and the LLCs 
express the bulk of the prostaglandin F2 alpha (PGF2α) receptors (PTGFR) (Fitz et al., 
1982; Mamluk et al., 1998; Wiltbank et al., 2012). The corpus luteum becomes highly 
vascularized in order to distribute progesterone, which inhibits the secretion of LH and thus 
prevents ovulation. For subsequent ovulation to occur the corpus luteum must regress, and 
this luteolysis can be triggered by PGF2α (Stouffer and Hennebold, 2015). Alternatively, 
when fertilization of the oocyte and implantation are successful, maternal recognition of 
pregnancy results in the maintenance of the corpus luteum which, in turn, plays a key role 
supporting the developing embryo. Anti-luteolytic mechanisms such as secretion of 
signaling molecules from the conceptus result in gene expression changes in the LLCs and 
SLCs (Romero et al., 2013). For example, both luteal cell types in ruminant species respond 
to the conceptus secretion of IFNT by increasing expression of ISG15 (interferon-stimulated 
gene, 15 kDa) (Romero et al., 2013). Thus, ovarian somatic cells play essential roles in 
oocyte and embryo fates.
1.2. Gene expression profiles of ovarian somatic cells
The physiological roles of GCs and TCs in the follicle are well studied in a variety of 
mammalian species including humans, non-human primates, rodents, sheep, and cattle 
(Edson et al., 2009). While there are some species-specific differences, many aspects of 
ovarian physiology are well conserved. A wide variety of microarray-based investigations 
have been performed in various species as well, often with the goal of understanding the 
changes in a single cell type in response to time, external stimuli, or disease conditions 
(Coskun et al., 2013; Kezele, 2005; McKenzie et al., 2004; Owens et al., 2002; Skinner et 
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al., 2008; Tsubota et al., 2011; Uyar et al., 2013; Wood et al., 2003; Xu et al., 2011). There 
are far fewer direct comparisons of the transcriptomes of specific cell types with the goal of 
identifying cell type markers and functional differences, but some have been performed 
including a recent direct comparison of the bovine GC and TC transcriptomes which 
identified cellular markers unique to GC and TC in addition to the traditional markers 
(steroidogenic enzymes and receptors) (Hatzirodos et al., 2015). Other studies have assessed 
the shifts in transcription patterns that occur in ovine and bovine GCs and TCs during 
follicular development (Bonnet et al., 2011 ; Hatzirodos et al., 2014a, b; Khan et al., 2016) 
or the gene expression changes in GCs and TCs during the attainment of follicle dominance 
and preovulatory status in the cow (Zielak et al., 2008) and the horse (Donadeu et al., 2014). 
However, characterization and comparison of the transcriptomes of GC and TC with LLC 
and SLC cell types is not currently available. Therefore, there is a gap in knowledge 
regarding how the follicular cells’ gene expression profiles relate to the luteal phase of the 
reproductive cycle.
The transition from follicle to corpus luteum has also not been fully addressed by microarray 
analyses, though there are publications covering the short-term changes that happen in 
bovine GCs and TCs in response to the luteinizing hormone (LH) surge and intrafollicular 
prostanoids (Christenson et al., 2013; Li et al., 2009). A study of the GCs before and after 
human chorionic gonadotropin (hCG) administration in women undergoing controlled 
ovarian stimulation identified many of the same differentially expressed genes (Wissing et 
al., 2014). Other research conducted on the transcriptome of the corpus luteum has focused 
on the mechanisms of luteal regression in cattle and non-human primates (Bogan et al., 
2009; Casey et al., 2005; Goravanahally et al., 2009) or on changes at progressive stages in 
the luteal life cycle (early, mid, mid-late, late, and very-late) (Bogan et al., 2008). However, 
these luteal microarrays did not distinguish between SLCs and LLCs.
1.3. Luteal cell type distinctions and lineages
There are currently no published microarray assessments of LLC and SLC gene expression 
profiles. What is known of the disparate functions of these cell types in sheep and cows 
comes from immunohistochemistiy, small-scale transcriptional analysis, and cell culture-
based experiments. The major known functional differences are that the basal progesterone 
secretion of LLCs is about 6–20× greater than that of SLCs, but SLCs are able to robustly 
respond to LH to amplify their progesterone production while LLCs have a modest 
steroidogenic response to LH (Alila et al., 1988; Fitz et al., 1982; Harrison et al., 1987). 
Importantly, in addition to the lack of a comprehensive transcriptome for LLCs and SLCs, 
the question of their cellular origin and lineage has not been addressed with the latest 
technologies. The prevailing understanding is that in cows LLCs originate from the GCs that 
remain in the follicle after ovulation while the TCs give rise to SLCs (Donaldson and 
Hansel, 1965; Hansel et al., 1991). With new technology and a comprehensive assessment of 
the transcriptomes of the GC, TC, SLC, and LLC populations, possible lineage markers for 
future investigation can be identified in addition to attaining an improved understanding of 
the relative functions of each cell type. Thus the objective of this study was to comparatively 
analyze RNA microarrays of these four ovarian somatic cells in order to corroborate existing 
GC and TC transcriptomes, provide novel transcriptome data for LLCs and SLCs, perform 
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bioinformatic analyses to expand on the functional roles of these cells in ovarian physiology, 
and determine whether the existing luteal cell lineage model is supported by transcriptome 
analysis.
2. Methods
2.1. Follicular cell isolation
Follicular granulosa (n = 4 cows) and theca cells (n = 3 cows) were isolated from estrogen-
active dominant follicles in ovaries of beef cows (75% Red Angus, 25% MARC III) from 
the physiology herd located at the University of Nebraska Agricultural Research and 
Development Center. The University of Nebraska-Lincoln Institutional Animal Care and 
Use Committee approved all procedures and facilities used in this experiment. Estrous 
cycles of cows were synchronized with a modified Co-Synch protocol using gonadotropin 
releasing hormone (GnRH) and a controlled internal drug release device (CIDR; 1.38 g 
progesterone, Zoetis) for 7 days with a PGF2α (25 mg/mL; Lutalyse, Pfizer Animal Health) 
injection at CIDR removal (Summers et al., 2014). Ovariectomy was performed 
approximately 36 h after CIDR removal (Youngquist et al., 1995). Upon ovariectomy, the 
largest (>10 mm diameter) antral follicle from each cow’s ovaries was aspirated/dissected 
and the granulosa cells (≥94% purity), theca cells (≥82% purity), and follicular fluid were 
isolated as described previously (Summers et al., 2014). The purity of the follicular cell 
types using the same isolation method was determined by culturing 1 K cells per chamber on 
a 4-chamber glass slide, performing immunofluorescence detection of aromatase and smooth 
muscle actin, and manually counting the cells of six randomly selected regions. For the 
microarray, both granulosa and theca cells were homogenized in Tri-reagent (Sigma-
Aldrich) for RNA isolation. It is important to note that follicles and RNA samples were 
collected from a large number of cows for use in various experiments, and those used for the 
microarray analyses were selected based on RNA quality and evidence of cell population 
enrichment. Thus, the GC and TC samples discussed in this article are not pairs from the 
same cows.
2.2. Luteal cell isolation
Luteal cells were isolated by elutriation from bovine corpora lutea of ovaries collected at a 
local abattoir (JBSSA, Omaha, NE) as described previously for cattle (Mao et al., 2013). 
Each corpus luteum (n = 3 cows for both LLC and SLC) was digested with collagenase to 
dissociate the cells, which were then suspended in a solution of DMEM (calcium free, 3.0 
g/L glucose, 25 mM HEPES, 3.8 g/L sodium bicarbonate; 0.1% BSA, 0.02 mg/mL 
deoxyribonuclease, pH 7.2) to a total volume of 30 mL Elutriation was then performed with 
a Beckman Coulter Avanti-J20X centrifuge with a JE 5.0 rotor. The cells were applied to a 
Sanderson (Beckman) elutriation chamber and the eluates were collected with continuous 
flow with each fraction comprising 100 mL of eluate. Cell number, approximate size, and 
viability in collected fractions were determined with trypan blue staining using a 
hemocytometer. Most of the endothelial cell population was removed in the first fraction, as 
freshly isolated endothelial cells are smaller than SLCs (O’Shea et al., 1989). As described 
previously, the second and third collected fractions contained ≥90% SLCs, while the fourth 
fraction contained a majority of LLCs (≥80%) along with some SLC and endothelial cells 
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(Mao et al., 2013). Cells with a diameter of 15–25 μm were classified as small luteal cells, 
and cells with a diameter >30 μm were classified as large luteal cells. This approach 
provided direct confirmation of the composition of the cell populations, and the potential for 
a small proportion of cells to be retained that are of similar sizes to the luteal cells is 
considered in the analysis. The average purity of SLC in F2 and LLC in F4 were 93.6 
± 1.5% and 83.3 ± 0.9% (n = 3). SLCs and LLCs were concentrated with additional 
centrifugation of the relevant fractions, and the cells were homogenized in Tri-reagent 
(Sigma-Aldrich) for RNA isolation.
2.3. Microarray transcriptome analysis
After RNA extraction, 200 ng RNA for each sample were submitted to the University of 
Nebraska Microarray Core facility where the Affymetrix Bovine GeneChip® Gene 1.0 ST 
Array RNA expression analysis was performed. The microarray results were normalized 
with Robust Multi-Array Averaging. Array analysis was then performed using the National 
Institute of Aging tool (http://lgsun.grc.nia.nih.gov/ANOVA/) for Analysis of Variance 
(ANOVA), hierarchical clustering, and correlation between replicates. All functional 
bioinformatic analyses were performed on transcripts above a linear noise threshold of 100. 
Functional categorization of genes was determined by examining Gene Ontology 
Annotations (included in the Affymetrix microarray probe annotations) in combination with 
the gene descriptions from Entrez Gene (NCBI, http://www.ncbi.nlm.nih.gov/gene) and 
UniProtKB/Swiss-Prot (http://www.uniprot.org/). Predicted cell function outcomes were 
assessed with Ingenuity® Pathway Analysis (IPA; Winter 2015 release, Qiagen). The 
Principle Component Analysis was performed in R using script written in collaboration with 
the University of Nebraska-Lincoln Dept, of Statistics. Statistical significance of differences 
between Eigenvalues was determined with a two-tailed Student’s T-tests with P < 0.005 
indicating a significant difference.
2.4. Quantitative real-time PCR
To validate the microarray results, quantitative real-time PCR (qPCR) was performed in 
triplicate on 384-well plates to amplify select targets from cDNA synthesized from the RNA 
samples originally used for the microarray using the primers listed in Table 1. Power 
SYBR™ Green Master Mix (Thermo-Fisher) was utilized with an Applied Biosystems 
7900HT Fast Real-Time PCR System. Expression was normalized to the geometric mean of 
the ribosomal RNA products RPL15 and RPL19. The results for each transcript are 
represented as fold-changes relative to the expression of that transcript in the cell type of 
interest.
3. Results and discussion
3.1. Cell type transcriptome clustering and correlation
To attain gene expression profiles for the somatic ovarian follicular and luteal cells, it was 
necessary to obtain a cell population that was highly enriched in a single cell type. Follicular 
cells were isolated from the ovaries of estrous-synchronized beef cows and the luteal cells 
were obtained from corpora lutea of beef cows from a local abattoir. The GC purity based on 
immunofluorescence (IF) against smooth muscle actin to detect any contaminating TCs was 
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≥94%. The TC population purity based on IF against aromatase to identify contaminating 
GCs was ≥82%. Using cell size, the LLC purity was ≥80% (contaminating cells may include 
clumps of endothelial cells or SLC and similarly sized fibroblasts or immune cells) and the 
SLC purity was ≥95% (contaminating cells may include clumps of endothelial cells or 
similarly sized fibroblasts or immune cells. Affymetrix RNA microarray analysis generated 
the transcriptome data (Romereim et al., 2016) [NCBI GEO GSE83524]. An overall low 
standard deviation profile indicated quality amplification, with slightly higher standard 
deviations for lower-intensity RNAs suggesting more variability for low copy-number 
targets [see Fig. 1 in accompanying Data in Brief article (Romereim et al., 2016)]. 
Hierarchical clustering to assess similarity between the gene expression profiles of the 
tissues showed that the follicular cell types (TC and GC) were similar to each other while 
the luteal cell types (LLC and SLC) were even more similar (Fig. 1A). The distance between 
branch points in the dendrogram, shown on the x-axis, indicates the degree of similarity 
between two samples (the shorter the distance, the greater the similarity in transcriptomes). 
The similar gene expression profiles of the luteal cells are likely due to their shared 
environment and related roles, but it is also important to note that the SLC and LLC samples 
are paired samples with each set originating from three different cows. In contrast, the GC 
and TC transcriptomes were not paired samples from the same cows but are still closely 
related on the dendrogram. The relationship between individual microarray replicates (each 
cell type from a separate cow) by hierarchical clustering confirmed that the gene expression 
profiles for all samples of the same cell type were highly similar (Fig. 1A). The degree of 
similarity in the samples’ transcriptomes was also represented quantitatively by a correlation 
matrix that compares each microarray replicate against every other replicate (Fig. 1B). The 
correlation between each replicate of the same cell type was ≥97.5%, which indicates quality 
isolation methods and experimental reproducibility. Additional verification of experimental 
reproducibility is evident in sections 3.2.1 and 3.2.2, as specific GC and TC markers 
identified by other investigators were detected in the GC and TC microarrays (Christenson et 
al., 2013; Hatzirodos et al., 2015). The LLCs and SLCs were also highly similar to each 
other based on overall gene expression profile correlation, but as will be shown later these 
luteal cell types did have some interesting distinctions in gene expression. The TC overall 
expression profile was 92–95% correlated to the GCs, SLCs, and LLCs; while the GC 
expression profile was <90% similar to the SLCs and LLCs. This broad view of the 
similarities between the RNA expression of each cell type suggests similarities in function 
and cellular environment.
3.2. Differentially expressed genes for each cell type
The transcriptomes for the follicular and luteal cells were analyzed in two complementary 
ways. First, each individual microarray (linear intensity for all transcripts) was investigated 
using the Ingenuity Pathway Analysis (IPA) tools that predict the functional outcome of a 
given gene expression profile. Most of these results were highly similar for all four cell types 
due to the fact that they have the same housekeeping genes, basic cellular functions, and a 
shared ovarian environment. Some of the most prominent shared functions include cell 
death, cell survival, cell cycle progression, proliferation, RNA expression, protein 
metabolism, and organization of cytoplasm (Table 2). When the shared predicted functions 
are excluded, though, several interesting differences were apparent for each cell type.
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The second analytical method used to assess the microarray data involved filtering the 
datasets so that only a subset of transcripts was used. Within each cell type there were sets of 
genes identified as differentially expressed for that cell type compared to the other three 
types [for a complete list see Tables 1, 2, 3, and 4 in (Romereim et al., 2016)]. Each set of 
genes that were differentially expressed (either ≥2-fold higher expression or ≥2-fold less 
compared to all three other cell types) was used for functional analyses (IPA, functional 
categorization) and to select targets for qPCR validation of the microarray results. The IPA 
input included the fold-changes for each transcript of the cell type of interest versus each of 
the other three cell types separately. Most of the differentially regulated genes were more 
highly expressed in their cell type, making them good candidates for cellular markers within 
the context of the ovarian follicle and corpus luteum. Six genes for each cell type were 
selected as marker genes (Table 3). Some published marker genes used to distinguish 
between GC and TC cells are also represented on this list. Preference for genes encoding 
membrane-bound proteins was also given to identify novel potential cell surface markers for 
flow cytometry and similar applications.
3.2.1. The GC transaiptome—The entire RNA expression profile of the GC samples 
revealed several features of the role of the GC in the ovary compared to the TCs, LLCs, and 
SLCs [available in (Romereim et al„ 2016)]. The shared housekeeping/ovarian predicted 
functions that were present in the other three cell types were predicted for the GC 
transcriptome, but there were also many GC-specific predicted functional outcomes (Table 
4). Select predicted functions unique to the GCs indicate abundant expression of genes 
involved in S phase and G2 phase, more specifically than the general cell cycle progression 
predicted for the other cell types (Table 4). There was also gene expression associated with 
cellular colony formation (related to proliferation and cellular adhesion), RNA decay and 
repression, and protein complex assembly. Interestingly, several other predicted functions 
that are connected to G-protein coupled receptor or tyrosine kinase receptor signaling were 
specific to GCs such as the formation of clathrin-coated structures that internalize receptors, 
small GTPase-mediated signal transduction, and protein phosphorylation (Table 4). These 
functions are likely related to FSH signaling. The transcriptome of the dominant follicle 
GCs indicated a cell population with rapid proliferation, abundant G-protein coupled 
receptor signaling (e.g. FSH signaling), and modified RNA dynamics (RNA decay and 
repression).
Using the filtered set of genes that are differentially expressed in GCs, other distinguishing 
characteristics of the GC population can be determined to supplement those based on the 
global microarray results. The largest set of differentially expressed targets was identified for 
the GCs (452 enriched RNAs and 115 decreased compared to TCs, LLCs, and SLCs). Select 
genes including some well-known GC markers (CYP19A1, FSHR, and INHBB) were 
validated with qPCR (Fig. 2A). The entire set of genes enriched in GCs is available in the 
accompanying Data in Brief article [see Table 1 in (Romereim et al.(2016)]. Several of the 
genes enriched in the GC transcriptome were also identified as GC markers by Hatzirodos et 
al., in 2015, including MGARP, GLDC, CHST8, SLC35G1, CA8, CLGN, FAM78A, and 
SLC16A3 [Table 1 in (Romereim et al., 2016; Hatzirodos et al., 2015)]. Only three of the 
markers in that article were not identified in the current microarray dataset: LOC404103, 
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CSN2, and GPX3 (Hatzirodos et al., 2015). The minor differences in the GC markers 
identified likely lies in the methods and timing of cell collection. The GCs represented here 
are from the dominant follicle from a synchronized and tracked estrous cycle, while 
Hatzirodos et al., 2015, collected all follicles >9 mm from unsynchronized ovaries obtained 
from an abattoir (Hatzirodos et al., 2015). In Fig. 2B, the functional classifications of the 
GC-specific/enriched genes are shown. Increased RNA detection of genes involved in 
mitosis, DNA replication/repair/structure, and signal transduction was evident. These 
proliferation and signaling functions are known to be crucial for the role that GCs play in 
follicular maturation. Some signaling receptors included in the GC gene set were receptors 
for FSH, estrogen, Eph/ephrins, interleukin 6, insulin-like growth factor 1, and thrombin. 
There were also many effector molecules upregulated in GCs compared to the TC, LLC, and 
SLC gene set including SMADs, PLC, kinases involved in signaling cascades like 
MAPK3K5, and especially G-protein signaling modulators like Rac GTPases and GEFs. 
The IPA-predicted consequences of the genes differentially regulated in GCs is summarized 
in Table 4. The primary predictions included increases in cell proliferation, survival, DNA 
replication and repair, and microtubule/chromosome rearrangement. These predicted 
functions support the idea that proliferation is indeed central to the GC population. The 
overall results of these GC array analyses confirmed existing knowledge about GC markers 
and functions, provided a solid foundation for comparisons with the other ovarian somatic 
cells, and identified novel GC markers.
3.2.2. The TC transcriptome—The global RNA expression profile of the TCs included 
the same prominent, shared IPA predicted functions as the other three cell types (Table 2). 
The predicted functions unique to the TC transcriptome included many cellular behaviors 
related to metabolism including glycolysis, aerobic respiration, metabolism of heme, 
oxidation of protein, synthesis of carbohydrate, and synthesis of sterols (Table 5). 
Interestingly, insulin-like growth factor signaling and growth of ovarian follicles were also 
predicted specifically for the TC population and not for the other ovarian cell types (Table 
5).
While the main conclusion of the predicted functions of the TC transcriptome was increased 
metabolic activities, the set of RNA transcripts enriched in TCs offered different insights. Of 
the set of genes differentially expressed in the TC samples compared to the GCs, LLCs, and 
SLCs [see Table 2 in (Romereim et al., 2016); 153 enriched RNAs and 11 decreased], 
selected targets were validated with qPCR (Fig. 3A). As with the GC gene expression 
profile, several of the genes enriched in these synchronized dominant follicle TC 
microarrays were also identified in unsynchronized ovaries by Hatzirodos et al., in 2015, as 
TC markers such as DCN, COL1A2, COL3A1, OGN, COL5A2, NID1, ACTA2, ACTG2, 
EGFLAM, ADAMDEC1 HPGD, COL12A1, LOXL1, and RARRES1 [see Table 2 in 
(Romereim et al., 2016) (Hatzirodos et al., 2015)]. The TC gene set included a greater 
proportion of extracellular matrix genes than the other cell types as shown by Gene 
Ontology analysis (Fig. 3B). This included several collagens, elastin, decorin, fibrillin, and 
proteins that bind to or link extracellular matrix proteins. Other categories of genes enriched 
in TCs included signaling (such as receptors for PDGF, endothelin, and VIP as well as 
secreted molecules like INSL3 and SLIT2) and protein/nucleotide metabolism. The 
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traditional TC steroidogenic enzyme CYP17A1 was also strongly enriched (Fig. 3A). Due to 
the smaller number of differentially expressed genes, the Ingenuity Pathway Analysis was 
only able to predict a small number of functions based on those genes, and few were relevant 
given the ovarian context (Table 5). For example, the predicted cell migration likely implies 
extracellular matrix remodeling and cytoskeletal dynamics rather than actual migration of 
theca cells. As with the GC array results, these TC transcriptomes analyses confirmed 
known marker genes and also indicated that the TC population is responsible for creating 
and modifying the extracellular matrix of the follicle, communicating with endothelial cells 
and GCs, and performing metabolic functions.
3.2.3. Shared genes enriched in both follicular cell types—The set of genes 
shared between the GC and TC populations that were enriched compared to both LLCs and 
SLCs provided information on what makes the follicular cells different from the luteal cells 
[see Table 5 in (Romereim et al., 2016); 708 enriched RNAs]. Functional analysis with IPA 
predicted that follicular cells (compared to luteal cells) have increased cell cycle progression 
and proliferation (multiple cyclins, cyclin-dependent kinases, and cell division cycle 
proteins), survival, organization of the cytoplasm and cytoskeleton (kinesins, dynein, 
cytoskeleton-associated proteins), and DNA replication and repair (e.g. DNA2, FANCC, 
FANCI, RAD51) (Table 6). This was accompanied by a predicted decrease in cell death, 
aneuploidy, and reproductive system hyperplasia. These predictions of active proliferation 
and growth are consistent with the known behavior of the dominant follicle just prior to the 
LH surge, the time when these samples were collected.
3.2.4. The LLC transcriptome—The IPA-predicted functional consequences of the 
entire set of LLC RNA transcripts included the typical housekeeping functions shared 
among all four cell types (Table 2) and also provided a variety of predicted functions 
specific to the LLCs. Many of these functions were related to adhesion (binding of cells, 
growth of epithelial tissue, and quantity of connective tissue) or cytoskeletal dynamics 
(microtubules and cell branching) (Table 7). These predicted cellular behaviors are 
consistent with the changes that occur during corpus luteum formation and LLC 
differentiation. Other functions included molecular transport, development of blood cells, 
production of reactive oxygen species, and cellular homeostasis (Table 7). The functions 
predicted for the LLC population did not include some known LLC behaviors such as lipid 
and protein production, but this is due to the fact that these are common to multiple cell 
types and were thus excluded by the analysis. The remaining LLC-specific functions 
covered behaviors necessary to maintain and support such a large cell including larger-scale 
cytoplasmic, membrane component, and cytoskeletal production/turnover.
In addition to the global cellular functions, the LLCs had a set of differentially expressed 
genes containing 300 enriched RNAs and 10 decreased transcripts when compared against 
the GC, TC, and SLC transcriptomes [see Table 3 in (Romereim et al., 2016)]. Selected 
genes were validated with qPCR, including the traditional LLC marker PTGFR (Fig. 4A). 
Of those genes specific to or enriched in the LLC samples, the greatest proportion was 
related to signaling (Fig. 4B). This includes receptors such as PTGER3, PDGFR, PRLR, 
FLT1, KDR, adrenergic receptor (ADRA2B), endothelin receptor (EDNRB), TGFBR2, and 
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TNFRSF21. As a note, prolactin regulates the luteotropic response in rodents but not in 
ruminants. Instead, prolactin is both produced within the bovine corpus luteum and regulates 
its vascularization (Erdmann et al., 2007; Shibaya et al., 2006). A specific role for prolactin 
signaling within in LLCs awaits discovery. Some secreted signaling molecules represented 
were VEGFA, PDGFA, PTHLH, and KHIG. The IPA predicted functional outcome of the 
LLC enriched set of genes included angiogenesis/vasculogenesis (.EFNB2, PDGFRB, 
VECFA), differentiation of cells (NOTCH3, PTHLH, TGFBR2, WNT11), immune and 
inflammatory response (chemo-kines, interleukins, tumor necrosis factor family molecules), 
synthesis of lipid (AC0X2, ACSL4, CYP7B1, RDH10), and ion transport (SLC7A8, 
ATP1B2) (Table 7). Overall, these data showed that the LLC population is actively engaged 
in cell-cell communication to recruit immune/endothelial cells as well as synthesize lipids 
while maintaining the adhesion, cytoskeleton, and homeostasis needed to support its large 
size.
3.2.5. The SLC transaiptome—The global SLC microarray results had many predicted 
functional consequences based on IPA, including those common to all four cell types (Table 
2). Among the predicted functions that were exclusive to the SLCs, many specific types of 
metabolism were found including metabolism of phospholipids, peptides, and sterols as well 
as regulation of the concentration of ATP (Table 8). Other functions were related to signal 
transduction such as dephosphorylation of proteins and oxidative stress response (Table 8). 
And, interestingly, cellular storage in the form of inclusion bodies made a sole appearance 
on the SLC list in addition to the transport of molecules and fluid into cells by pinocytosis 
(Table 8). The large-scale transcript comparison thus suggested that the SLCs were 
performing different metabolic, signaling, and storage functions than LLCs and follicular 
cells.
While the whole SLC transcriptome yielded a wide variety of results, the SLC samples had 
the fewest differentially represented RNAs with 48 increased and 12 decreased relative to 
GCs, TCs, and LLCs [see Table 4 in (Romereim et al., 2016)]. A few select genes were 
validated by qPCR (Fig. 5A) including the canonical SLC marker LHCGR. It has been 
previously determined that the SLCs contain the majority of LH receptors in the bovine 
corpus luteum, but that LHCGR expression does occur in the bovine LLCs (Mamluk et al., 
1998). However, the LHCGR expression activity in the LLCs can change based on external 
stimuli such as seasonal changes and exogenous hormonal treatments, suggesting the 
possibility that the disparity in SLC and LLC LHCGR expression may vary (Wiltbank, 
1994). Additionally, LHCGR is even less suited to be a marker gene when all four cell types 
are considered since that gene is expressed in both GCs and TCs (with the level of 
expression depending on the stage in follicular development). The greatest number of the 
genes were involved in signal transduction (Fig. 5B). This included both receptors and 
ligands related to BMP signaling, complement components involved in immune response, 
and effector molecules such as kinases and phospholipases. Interestingly, the receptor KIT 
was present in the SLCs that corresponds to the KITLG produced by the LLCs. Previous 
work has also demonstrated that TCs express KIT to communicate with GCs, which express 
KITLG (Parrott and Skinner, 1997). Due to the small set of genes involved, functional 
assessment with IPA yielded only two predicted increased behaviors: aggregation of 
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platelets and cancer (Table 8). Neither prediction shed much extra light on the SLCs within 
the context of ovarian biology. The set of genes enriched in SLCs, however, was useful in 
determining the distinguishing characteristics between LLCs and SLCs, which were 
primarily the predominant active signaling pathways and some differences in extracellular 
matrix (COL6A1, MMP7, CCBE1) and adhesion (CLDN1).
3.2.6. Shared genes enriched in both luteal cell types—When comparing the 
luteal cells as a group to the follicular cells, 792 RNA transcripts were enriched in the LLC 
and SLC populations together compared to both the GC and TC samples [see Table 6 in 
(Romereim et al., 2016)]. IPA assessment of the transcripts enriched in both luteal cell types 
indicated increased metabolism/synthesis of lipids and steroids (cholesterol, eicosanoid, 
sterol, terpenoid, fatty acids, lipid membranes), cellular proliferation and survival, cell 
maturation, increased quantity of gonad, inflammatory and immune response, angiogenesis 
and migration of endothelial cells, and cell-to-cell signaling among other functions (Table 
9). An additional consideration with the luteal cell microarrays is that the process of 
elutriation causes mechanical stresses to the cells. The duration of the elutriation may allow 
transcription of some early-response stress genes. Shared luteal cell microarray detection of 
RNAs such as JUN, JUNB, JUND, NFKB2, EGR1, EGR2, FOS, and FOSB could be due to 
in vivo signaling responses or to the cellular isolation procedure.
3.3. Gene expression patterns and Principle Component Analysis
Beyond determining differentially expressed gene sets and evaluating the predicted 
functional consequences, another method to analyze large datasets is Principle Component 
Analysis (PCA). With this statistical tool, patterns of gene expression are grouped into 
Principle Components (PC) that have their own Eigenvector (a vector within a matrix) and 
each sample is given an Eigenvalue corresponding to how well it fits each PC (i.e. gene 
expression pattern). The first PC explains the most variation within the dataset, and two to 
three PCs should incorporate almost all of the variation. If two or three PCs are graphed 
(either in two dimensions or in 3D) with the Eigenvalues converted to graphing coordinates, 
the variation between samples is easily visualized. A two-dimensional representation of PC1 
and PC2 shows that the microarray replicates of the same cell type clustered together (Fig. 
6). This supported the hierarchical clustering results shown in Fig. 1A. However, unlike with 
hierarchical clustering based on the global transcriptome for each microarray replicate, PCA 
emphasizes variability in the data to tease out potential relationships and make those 
relationships easier to visualize. In Fig. 6, using PC1 (which covers 79.15% of the 
expression variance) as the x-axis placed the LLC and SLC populations adjacent to each 
other (and not statistically significant via t-test) and indicated their close relationship in 
terms of gene expression patterns. Interestingly, the GC and TC populations were furthest 
apart (emphasizing variability between the two populations) but TC and SLC were next to 
each other and the LLC and GC samples were also adjacent (and had mean PC1 eigenvalues 
that are not significantly different). This suggested a relationship between GC and LLC and 
between TC and SLC, supporting the existing lineage model. However, PCA cannot 
conclusively establish lineages, so future studies are needed to directly demonstrate this 
model.
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3.4. Transcriptional effects of GC and TC luteinization
Based on these microarrays, there were markers that are highly enriched or specific to each 
cell type and also potential lineage markers based on genes that were enriched in both GCs 
and LLCs or in both TCs and SLCs (Table 2, Fig. 7). The process of luteinization is a 
dramatic change in the morphology and function of the follicle, so the substantial differences 
in the gene expression profiles of the follicular cells and the luteal cells is understandable. 
Previous microarray analyses have investigated the TCs and GCs immediately before and 
after the LH surge that triggers ovulation and luteinization. Thus, it is possible to look for 
gene expression changes in the TCs and GCs caused by the LH surge that could be 
maintained by SLCs and LLCs. Based on microarray data from Christenson et al., 2013, 
some specific gene expression changes in GCs and TCs in response to the LH surge are 
compatible with a transition to specific luteal cell types.
While the synchronized dominant follicles for these GC and TC microarrays were collected 
approximately 36 h after injection with PGF2α to harvest pre-ovulatory follicular cells, the 
dominant follicles for the Christenson et al., 2013, microarrays were either collected without 
PGF2α during the height of the first follicular wave (pre-LH samples) or after a series of 
injections to create an LH surge (PGF2α, a 48-h wait, a GnRH analog injection, and another 
23-h wait to allow the cells time to respond to the LH) (Christenson et al., 2013). The GCs 
and TCs compared here to luteal cells and the periovulatory/post-LH GCs and TCs from 
Christenson et al., 2013, are thus only separated by approximately 36 h (with the data in this 
manuscript providing the earlier time point) and an LH surge. The transformation that 
happens during that event, however, provides an intermediate step between follicular cells 
and luteal cells. As part of that shift, there were gene expression changes in TCs in response 
to the LH surge that are compatible with a transition to an SLC phenotype including a 
decrease in expression of CYP17A1, SLC1A3, TRAF5, TSPAN33, and HPGD concurrent 
with increased expression of RHOB [see Table 4 in (Romereim et al., 2016)] (Christenson et 
al., 2013). There were even more parallels when assessing the effects of the LH surge on 
GCs. The loss of GC expression of CYP19A1, CHST8, HSD17B1, GCLC, SLC35G1, and 
GPT along with the gain of expression of PTX3, RUNX2, POSTN, RND3, TIMP1, NTS, 
FOS, and RCAN1 are all consistent with a switch from a GC transcriptome to an LLC gene 
expression profile [see Table 3 in (Romereim et al., 2016)] (Christenson et al., 2013). Thus, 
comparing microarray results provides an idea of the immediate changes during luteinization 
that are maintained when the luteal phenotype is attained.
4. Conclusions
After analyzing the RNA profiles of the follicular GCs and TCs and the LLCs and SLCs of 
the corpus luteum, we have determined cellular expression markers for each population 
(both novel genes and validation of previously identified markers). We have also assessed 
the functional implications of the differentially expressed genes for each cell type and 
follicular/luteal cells as groups. These analyses are especially beneficial for the LLCs and 
the SLCs, for which no transcriptome analysis is yet published. Further microarray 
comparative analysis has provided both support and potential markers for the lineage model 
that predicts that LLCs come from GCs and TCs primarily differentiate into SLCs.
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Fig. 1. 
Hierarchical clustering and correlation matrix of all microarray replicates. (A) Hierarchical 
cluster dendrograms indicate the degree of similarity between cell types and individual 
replicates using the distance at which the branch point occurs. The replicates within a cell 
type cluster closely together, and the two follicular cell types and two luteal cell types also 
cluster together. (B) The correlation matrix allows a quantitative comparison of any two 
microarray replicates. A correlation value of 1 indicates that the two replicates compared are 
identical, and the correlation between each replicate of the same cell type is ≥ 97.5% (red). 
The large luteal cells (LLCs) and small luteal cells (SLCs) are also highly similar (>95% and 
<97%, red), the theca cells (TCs) have an overall expression profile that is 92–95% 
correlated to the granulosa cells (GCs), SLCs, and LLCs (orange), and the GC expression 
profile is <90% similar to the SLCs and LLCs (yellow). (For interpretation of the references 
to colour in this figure legend, the reader is referred to the web version of this article.)
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Fig. 2. 
Granulosa cell-enriched gene set validation and functional categorization. (A) Validation of 
select granulosa cell (GC)-enriched genes with qPCR (blue) compared to the microarray 
fold changes (orange). (B) Functional categorization of genes enriched in GC samples 
shown as a percentage of the 567 differentially regulated transcripts.
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Fig. 3. 
Theca cell-enriched gene set validation and functional categorization. (A) Validation of 
select theca cell (TC)-enriched genes with qPCR (blue) compared to the microarray fold 
changes (orange). (B) Functional categorization of genes enriched in TC samples shown as a 
percentage of the 164 differentially regulated transcripts.
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Fig. 4. 
Large luteal cell-enriched gene set validation and functional categorization. (A) Validation 
of select large luteal cell (LLC)-enriched genes with qPCR (blue) compared to the 
microarray fold changes (orange). (B) Functional categorization of genes enriched in LLC 
samples shown as a percentage of the 311 differentially regulated transcripts.
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Fig. 5. 
Small luteal cell-enriched gene set validation and functional categorization. (A) Validation 
of select small luteal cell (SLC)-enriched genes with qPCR (blue) compared to the 
microarray fold changes (orange). (B) Functional categorization of genes enriched in SLC 
samples shown as a percentage of the 60 differentially regulated transcripts.
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Fig. 6. 
Principle Component Analysis of microarray replicates. The gene expression profile data for 
each microarray was transformed with Principle Component Analysis to visualize 
relationships between samples and emphasize variation by graphing them in two dimensions 
based on Principle Component 1 (PC1) and PC2. The individual microarray replicates 
within a sample type cluster together, and the Eigenvalues for PC1 (x coordinates) indicate 
that granulosa cells (GC) and large lutea cells (LLC) share gene expression patterns (average 
PC1 Eigenvalues not significantly different) as do theca cells (TC) and small luteal cells 
(SLC).
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Fig. 7. 
Diagram of the expression of the identified cell-type makers and potential lineage markers. 
The ovarian follicle and the corpus luteum and the major cell types present are illustrated. 
The expression of the newly identified and canonical (indicated with *) cellular markers are 
shown along with the potential lineage markers.
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Table 4
Predicted functional consequences of the granulosa cell transcriptome.
Category and functional annotation p-Value # RNAs
Select predicted functional consequences of the entire CC transcriptome
Assembly of protein-protein complex 1.17E-04 85
Colony formation of cells 2.55E-04 200
Decay of RNA 7.31E-05 18
G2 phase 4.36E-08 126
Morphology of clathrin-coated structures 2.64E-04 33
Phosphorylation of protein 1.93E-04 292
Repression of RNA 2.99E-04 77
S phase 8.29E-11 131
Small GTPase mediated signal transduction 1.53E-04 81
Predicted functional consequences of the genes enriched/decreased in CCs vs. TCs, LLCs, and SLCs
Select granulosa cell functions with increased predicted activation state (z-score >2)
Alignment of chromosomes 2.97E-12 12
Cell survival 1.51E-04 78
Cycling of centrosome 3.34E-07 14
Formation of microtubules 2.83E-03 8
Growth of connective tissue 9.88E-08 53
Invasion of cells 1.54E-04 51
Metabolism of DNA 1.07E-08 40
Proliferation of cells 4.25E-06 187
Repair of cells 9.93E-04 9
Repair of DNA 3.14E-05 25
Synthesis of DNA 7.90E-10 42
Select granulosa cell functions with decreased predicted activation state (z-score < −7)
Aneuploidy 9.89E-05 10
Cell death 2.06E-07 180
DNA damage 1.41E-06 21
Formation of mitotic spindle 5.17E-07 12
Fragmentation of nucleus 9.31E-04 6
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Table 5
Predicted functional consequences of the theca cell transcriptome.
Category and functional annotation p-Value # RNAs
Select predicted functional consequences of the entire TC transcriptome
Aerobic respiration of cells 1.90E-04 14
Glycolysis of cells 1.62E-04 50
Growth of ovarian follicle 3.41E-05 29
Insulin-like growth factor receptor signaling pathway 1.89E-04 11
Metabolism of heme 1.61 E-04 10
Oxidation of protein 1.75E-06 19
Synthesis of carbohydrate 1.40E-04 182
Synthesis of sterol 4.14E-05 39
Tetramerization of protein 7.83E-06 56
Predicted functional consequences of the genes enriched/decreased in TCs vs. GCs, LLCs, and SLCs
Select theca cell functions with increased predicted activation state (z-score >2)
Development of urinary tract 1.91E-03 9
Formation of kidney 5.81E-03 8
Migration of cells 1.31E-02 30
Select theca cell functions with decreased predicted activation state (z-score < −2)
Aortic disorder 2.95E-03 6
Congenital anomaly of musculoskeletal system 6.29E-06 21
Hypoplasia of thorax 7.81E-03 6
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Table 7
Predicted functional consequences of the large luteal cell transcriptome.
Category and functional annotation p-Value # RNAs
Select predicted functional consequences of the entire LLC transcriptome
Binding of cells 7.00E-06 201
Branching of cells 2.63E-08 183
Cellular homeostasis 6.06E-10 702
Development of blood cells 2.11E-07 319
Growth of epithelial tissue 1.02E-07 309
Microtubule dynamics 4.86E-08 532
Production of reactive oxygen species 6.91E-06 159
Quantity of connective tissue 2.74E-06 269
Transport of molecule 1.20E-07 701
Predicted functional consequences of the genes enriched/decreased in LLCs vs. CCs, TCs, and SLCs
Select large luteal cell functions with increased predicted activation stale (z-score >2)
Activation of cells 8.92E-11 52
Angiogenesis 5.85E-31 82
Cell cycle progression 2.64E-04 39
Cell movement 6.82E-25 116
Cell survival 1.36E-11 68
Cellular homeostasis 2.28E-07 63
Chemotaxis 1.16E-11 38
Development of cytoplasm 8.97E-05 23
Differentiation of cells 6.62E-16 104
Endocytosis 2.19E-05 20
Formation of cytoskeleton 8.03E-05 20
Inflammatory response 1.23E-13 50
Ion homeostasis of cells 3.73E-05 27
Maturation of cells 2.60E-07 27
Migration of cells 4.60E-26 111
Migration of endothelial cells 1.51E-14 33
Proliferation of cells 1.79E-17 146
Quantity of Ca2+ 8.67E-06 23
Quantity of metal ion 4.13E-06 25
Synthesis of DNA 8.06E-07 25
Synthesis of lipid 5.28E-06 35
Transport of ion 8.11E-05 24
Select large luteal cell functions with decreased predicted activation state (z-score < −2)
Apoptosis 1.38E-11 106
Cell death 5.33E-12 125
Glucose metabolism disorder 1.18E-05 47
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Table 8
Predicted functional consequences of the small luteal cell transcriptome.
Category and functional annotation p-Value # RNAs
Select predicted functional consequences of the entire SLC transcriptome
Metabolism of phospholipid 2.78E-06 109
Metabolism of peptide 1.48E-05 86
Dephosphorylation of protein 1.01E-04 71
Migration of epithelial cells 3.16E-05 57
Concentration of ATP 1.09E-04 55
Metabolism of sterol 1.64E-05 52
Formation of cellular inclusion bodies 4.53E-05 43
Oxidative stress response of cells 5.51E-06 33
Pinocytosis 7.39E-05 19
Predicted functional consequences of the genes enriched/decreased in SLCs vs. GCs, TCs, and LLCs
Select small luteal cell functions with increased predicted activation state (z-score >2)
Category and Functional Annotation p-Value # RNAs
Aggregation of blood platelets 8.36E-04 5
Cancer 2.13E-03 54
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